MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,730 Cr | ₹1,538 Cr | ₹848 Cr | ₹576 Cr | ₹388 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹1,730 Cr |
| Mar2025 | ₹1,538 Cr |
| Mar2024 | ₹848 Cr |
| Mar2023 | ₹576 Cr |
| Mar2022 | ₹388 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,730 Cr | 12.43 | |
| Mar2025 | ₹1,538 Cr | 81.35 | |
| Mar2024 | ₹848 Cr | 47.16 | |
| Mar2023 | ₹576 Cr | 48.50 | |
| Mar2022 | ₹388 Cr | - | |
Compare Sundry Debtors of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹95,900.7 Cr | -1.6% | -4.8% | -8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.6% |
-4.8% |
-8.4% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses